01. Welcome
02. Stephen White – EBF – The regulatory landscape
03. Stuart Mc Dougall – EBF – Survey results
04. Claude Delatour – UCB BioPharma
05. Stefan Blech – BI
06. Graeme Young – GlaxoSmithKline
07. Geert Mannens – Janssen RD
08. Martha Green – Charles River
09. Philip Timmerman – EBF – afternoon breakout intro